Closing Bell: Nervgen Pharma Corp flat on Tuesday (NGEN)
Today during trading, Nervgen Pharma Corp shares closed at $2.80 after opening the day at $2.87. prices ranged from $2.80 to $2.87.
Share prices $verbed percentage_change% from the previous day's close of $2.80.
Today across North America, the TSX Composite closed 0.20% at 22824.67, the S&P 500 closed 0.08% at 5463.54, the Dow Jones Industrial Average closed -0.12% at 40539.93 and the Nasdaq Composite closed 0.07% at 17370.20.
Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.
A total of 9,679 shares was traded during the last trading day, with total trades of 35, with an average volume of 38,134 in the last five days.
Trading across the entire TSX-V saw 2,584 price advancers against 2,644 declines and 86 unchanged.
During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, the shares have soared 72.84% in the last 52 weeks, while they have advanced 3.70% since the start of 2024.
Following today's trading, Nervgen Pharma Corp has a market capitalization of $195.80 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.
Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.
Currently, Nervgen Pharma Corp has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..